Manuel Salto-Tellez Selected Research

Breast Neoplasms (Breast Cancer)

1/2023	Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
1/2023	Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
1/2023	Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
6/2021	The clinical and molecular significance associated with STING signaling in breast cancer.
1/2021	In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
1/2018	Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
1/2017	Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.
12/2015	Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention.
3/2015	Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.
5/2014	Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Salto-Tellez Research Topics

Disease

95	Neoplasms (Cancer) 05/2024 - 01/2003
33	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2003
30	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2008
12	Colonic Neoplasms (Colon Cancer) 01/2023 - 09/2008
12	Stomach Neoplasms (Stomach Cancer) 05/2016 - 09/2005
10	Adenocarcinoma 01/2020 - 01/2010
8	Inflammation (Inflammations) 05/2024 - 07/2005
7	Carcinoma (Carcinomatosis) 05/2016 - 11/2007
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2010
5	Hepatocellular Carcinoma (Hepatoma) 05/2015 - 07/2008
4	Microsatellite Instability 01/2022 - 01/2016
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2007
4	Carcinogenesis 04/2012 - 09/2008
3	Disease Progression 01/2023 - 09/2018
3	Bites and Stings (Sting) 06/2021 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2011
3	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 12/2008
3	Astrocytoma (Pilocytic Astrocytoma) 09/2018 - 10/2006
3	Genomic Instability 05/2014 - 05/2011
3	Lymphoma (Lymphomas) 03/2011 - 10/2008
2	Pneumonia (Pneumonitis) 06/2023 - 07/2005
2	Glioma (Gliomas) 04/2023 - 09/2018
2	Polyps 03/2023 - 02/2009
2	Hypoxia (Hypoxemia) 10/2020 - 05/2015
2	Neuroblastoma 08/2017 - 11/2013
2	Necrosis 12/2014 - 02/2009
2	Ovarian Neoplasms (Ovarian Cancer) 08/2011 - 01/2010
2	Hyperplasia 07/2011 - 10/2010
2	Metaplasia 06/2011 - 05/2011
2	Ductal Carcinoma 10/2010 - 01/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2010 - 01/2009
2	Fibrosis (Cirrhosis) 11/2009 - 12/2004
2	Adenoma (Adenomas) 02/2009 - 09/2008
2	Teratoma (Teratoid Tumor) 01/2009 - 01/2009
2	Hyperglycemia 01/2009 - 01/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024
1	Lung Diseases (Lung Disease) 06/2023
1	Pathologic Processes 06/2023
1	Adenomatous Polyps 03/2023
1	COVID-19 07/2021

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2003
39	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2003
17	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2007
11	Messenger RNA (mRNA)IBA 06/2023 - 07/2006
9	Formaldehyde (Formol)FDA Link 06/2023 - 01/2010
9	ErbB Receptors (EGF Receptor)IBA 08/2017 - 11/2007
8	ParaffinIBA 06/2023 - 01/2010
8	RNA (Ribonucleic Acid)IBA 12/2021 - 06/2013
8	Transcription Factors (Transcription Factor)IBA 03/2014 - 07/2006
6	Estrogen ReceptorsIBA 01/2023 - 01/2003
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2003
5	Small Interfering RNA (siRNA)IBA 03/2014 - 11/2009
5	Core Binding Factor Alpha 3 SubunitIBA 10/2010 - 07/2006
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2016
4	Cadherins (E-Cadherin)IBA 05/2016 - 11/2009
4	Fluorouracil (Carac)FDA LinkGeneric 02/2014 - 03/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2003
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 09/2015
3	ChemokinesIBA 01/2021 - 06/2016
3	Nucleic AcidsIBA 07/2019 - 12/2013
3	EnzymesIBA 03/2019 - 07/2012
3	Phosphotransferases (Kinase)IBA 01/2016 - 10/2008
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 04/2003
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 03/2013 - 07/2005
3	matrigelIBA 01/2012 - 07/2006
2	PlatinumIBA 01/2021 - 11/2019
2	B7-H1 AntigenIBA 04/2020 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2019 - 04/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 04/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 05/2016
2	GelsolinIBA 05/2016 - 01/2012
2	Indicators and Reagents (Reagents)IBA 03/2016 - 11/2007
2	LipidsIBA 03/2015 - 02/2010
2	Metalloproteases (Metalloproteinases)IBA 09/2014 - 10/2011
2	LigandsIBA 05/2014 - 11/2009
2	PPAR gammaIBA 05/2014 - 11/2009
2	Tyrosine Kinase InhibitorsIBA 11/2013 - 10/2011
2	GYY 4137IBA 03/2013 - 07/2009
2	Androgen Receptors (Androgen Receptor)IBA 07/2012 - 01/2010
2	Hormones (Hormone)IBA 01/2010 - 10/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2009 - 09/2005
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2009 - 02/2009
2	LipopolysaccharidesIBA 07/2009 - 07/2005
2	Monoclonal AntibodiesIBA 01/2009 - 09/2005
2	Streptozocin (Streptozotocin)FDA Link 01/2009 - 01/2009
1	HMGB1 Protein (HMG1)IBA 03/2023
1	Aromatase InhibitorsIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	SuspensionsIBA 07/2021
1	VaccinesIBA 07/2021
1	InterferonsIBA 06/2021

Therapy/Procedure

27	Therapeutics 04/2023 - 01/2003
12	Drug Therapy (Chemotherapy) 01/2021 - 07/2008
4	Adjuvant Chemotherapy 10/2018 - 01/2016
3	Immunotherapy 06/2021 - 01/2016
3	Precision Medicine 01/2020 - 12/2008
3	Transplantation 05/2014 - 01/2009
2	Neoadjuvant Therapy 11/2019 - 03/2019
2	Lasers (Laser) 06/2011 - 12/2007